Evidence map›Paper›PMID 35278018›Full record

ArticleMolecular plant pathology2022

Role of the FnIII domain associated with a cell wall-degrading enzyme cellobiosidase of Xanthomonas oryzae pv. oryzae.

Rajkanwar Nathawat, Roshan V Maku, Hitendra K Patel, Rajan Sankaranarayanan, Ramesh V Sonti

Open access · goldAbstract read
In one paragraph

Article in Molecular plant pathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Pathogens (Basel, Switzerland) · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rajkanwar NathawatCSIR - Centre for Cellular and Molecular Biology, Hyderabad, India.ORCID 0000-0003-1089-5461
Roshan V MakuCSIR - Centre for Cellular and Molecular Biology, Hyderabad, India.
Hitendra K PatelCSIR - Centre for Cellular and Molecular Biology, Hyderabad, India.
Rajan SankaranarayananCSIR - Centre for Cellular and Molecular Biology, Hyderabad, India.ORCID 0000-0003-4524-9953
Ramesh V SontiCSIR - Centre for Cellular and Molecular Biology, Hyderabad, India.ORCID 0000-0003-4845-0601
Centre for Cellular and Molecular Biology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cellobiosidase (CbsA) is an important secreted virulence factor of Xanthomonas oryzae pv. oryzae (Xoo), which causes bacterial blight of rice. CbsA is one of several cell wall-degrading enzymes secreted by Xoo via the type II secretion system (T2SS). CbsA is considered a fundamental virulence factor for vascular pathogenesis. CbsA has an N-terminal glycosyl hydrolase domain and a C-terminal fibronectin type III (FnIII) domain. Interestingly, the secreted form of CbsA lacks the FnIII domain during in planta growth. Here we show that the presence of the FnIII domain inhibits the enzyme activity of CbsA on polysaccharide substrates like carboxymethylcellulose. The FnIII domain is required for the interaction of CbsA with SecB chaperone, and this interaction is crucial for the stability and efficient transport of CbsA across the inner membrane. Deletion of the FnIII domain reduced virulence similar to ΔcbsA Xoo, which corroborates the importance of the FnIII domain in CbsA. Our work elucidates a hitherto unknown function of the FnIII domain in enabling the virulence-promoting activity of CbsA.

Indexed as

OryzaXanthomonasBacterial ProteinsCell WallGene Expression Regulation, BacterialGlycoside HydrolasesPlant DiseasesVirulence FactorsBacterial ProteinscellobiosidaseGlycoside HydrolasesVirulence FactorsexoglucanaseFnIII domainricesecretiontype II secretion systemvirulenceXanthomonas

Identifiers

PMID35278018
PMCPMC9190976
OpenAlexW4221068801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.